Scope and Standards of the RME

Question 1

Hyperplasia

Answer 1

An abnormal increase in the number of cells in an organ or tissue.

Question 2

Dysplasia

Answer 2

The presence of abnormal cells within a tissue or organ.

Question 3

Neoplasia

Answer 3

Abnormal and uncontrolled cell growth that alters normal functions of host tissue, physiology, or function. A neoplasm may be benign or malignant (cancer).

Question 4

Tumor

Answer 4

An abnormal mass of tissue that results when cells divide more than they should or do not die when they should. Tumors may be benign (not cancerous), or malignant (cancerous). Also called neoplasm.

Question 5

Benign

Answer 5

Not cancerous. Benign tumors may grow larger but do not spread to other parts of the body. They can cause damage and/or death for the host.

Question 6

Malignant

Answer 6

Cancerous. Malignant tumors can invade and destroy nearby tissue and spread to other parts of the body.

Question 7

Cancer

Answer 7

A term for diseases in which abnormal cells divide without control and aggressively migrate or are transported to other organs in the host.

Question 8

Metastasis

Answer 8

The development of secondary malignant growths at a distance from a primary site of cancer.

Question 9

Hematuria

Answer 9

The presence of red blood cells (either gross or microscopic) in the urine above specified laboratory values. For the purposes of this exam, 3 or more RBCs per high power field (HPF) that persist upon repeat testing is considered hematuria.

Question 10

Anemia

Answer 10

Medically called erythrocytopenia. Low number of red blood cells or a low amount of hemoglobin in your red blood cells. Red blood cells use iron to create hemoglobin; therefore, anemia may develop if your body does not have enough iron. Hemoglobin is a protein that helps carry oxygen through the body.

Question 11

Complete Blood Cell Count (CBC)

Answer 11

Laboratory test to determine the concentration of white blood cells (WBCs), red blood cells (RBCs), platelets (PLT), Hemoglobin (HgB), Hematocrit (HCT) and other cellular elements in the blood.
(a) Used to evaluate the overall health of a patient. The test can detect a wide range of disorders, including anemia, infection, and leukemia.
(b) Only the WBC and HCT are utilized for the RME per NAVMED P-5055.

Question 12

White Blood Cell Count (WBC)

Answer 12

Laboratory test to determine the number of white blood cells (WBCs) in the blood.
Expressed as WBC per cubic millimeter (mm) which is a unit of volume.

Question 13

Hematocrit (HCT)

Answer 13

Measures the percentage of the volume of whole blood that is made up of Red Blood Cells (RBCs).
Expressed as a percentage.

Question 14

CBC with Differential

Answer 14

Breaks down the different types of white blood cells.

Question 15

Urinalysis (UA)

Answer 15

Physical, chemical, and microscopic examination of urine.
The RME only requires microscopic analysis of RBCs via a HPF.

Question 16

Radiobioassay

Answer 16

The determination of kinds, quantities, or concentrations, and, in some cases, the locations of radioactive material in the human body.
(a) In Vivo – The measurement of radioactive material in the human body utilizing instrumentation that detects radiation emitted from the radioactive material in the body. Internal monitoring.
(b) In Vitro – The measurement or analysis of radionuclides in excreta (e.g., feces, urine) or other biological samples removed from the body.
(c) Used for internal dose calculations to determine the committed dose equivalent to an organ and/or the effective committed dose equivalent to the whole body.

Question 17

To which time requirements are RME labs subject?

Answer 17

3 months.